Implementation of a Clinical Pharmacist in a Hemodialysis Facility: A Quality Improvement Report

被引:21
作者
Daifi, Chantale [1 ,2 ]
Feldpausch, Brian [1 ]
Roa, Pia-Allison [1 ]
Yee, Jerry [2 ]
机构
[1] Henry Ford Hlth Syst, Div Community Care Serv, Dept Pharm, Detroit, MI USA
[2] Henry Ford Hosp, Div Nephrol & Hypertens, Detroit, MI 48202 USA
关键词
MEDICATION THERAPY MANAGEMENT; MAINTENANCE DIALYSIS;
D O I
10.1016/j.xkme.2020.11.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Hemodialysis (HD) patients have complicated disease states, placing them at higher risk for medication-related problems, medication discrepancies, and nonadherence. The objective of this study is to evaluate the impact of a clinical pharmacist in a single HD facility by assessing the efficacy of medication reconciliation in HD patients and evaluating the potential impact on a single health care system. Study Design: Retrospective study. Setting & Participants: Greenfield Health Systems, a wholly owned subsidiary of Henry Ford Health System, operates 14 HD facilities throughout Southeast Michigan. The West Pavilion facility is located in Detroit, MI. Patients with end-stage kidney disease included in the study had a minimum of 4 encounters with the clinical pharmacist or pharmacy interns between August 2017 and October 2018. Exposure: A clinical pharmacist performed medication reconciliation and medication reviews with HD patients to assess medication-related problems and identify gaps in care. Interventions made by the pharmacist were prespecified through a collaborative practice agreement. Outcomes: To evaluate the impact of a clinical pharmacist in an HD facility by assessing the efficacy of medication reconciliation in HD patients and evaluating the potential impact on this health system through an estimated cost avoidance. Analytical Approach: Descriptive statistics were used to collect medication-related problems and classified based on a modified Hepler-Strand approach. Results: There were 1,403 medication-related problems, with an average of 8.96 medication-related problems per patient. Adherence was the most common medication-related problem (31%). Antihypertensive medication was the most common drug class in which the pharmacist intervened (37%), followed by vitamin D analogues and calcimimetics (29%). A projected total of US $447,355 was saved. Limitations: Retrospective analysis of observational data and descriptive statistics with the potential for residual bias and confounding. Conclusions: Pharmacists in HD facilities have a positive influence on HD patients through medication management that results in cost savings.
引用
收藏
页码:241 / +
页数:8
相关论文
共 13 条
[1]   Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing [J].
Alshamrani, Majed ;
Almalki, Abdullah ;
Qureshi, Mohamed ;
Yusuf, Oyindamola ;
Ismail, Sherine .
PHARMACY, 2018, 6 (03)
[2]   Analysis of Pharmacist-Provided Medication Therapy Management (MTM) Services in Community Pharmacies Over 7 Years [J].
Barnett, Mitchell J. ;
Frank, Jessica ;
Wehring, Heidi ;
Newland, Brand ;
VonMuenster, Shannon ;
Kumbera, Patty ;
Halterman, Tom ;
Perry, Paul J. .
JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (01) :18-31
[3]   Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients [J].
Chiu, Yi-Wen ;
Teitelbaum, Isaac ;
Misra, Madhukar ;
de Leon, Essel Marie ;
Adzize, Tochi ;
Mehrotra, Rajnish .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (06) :1089-1096
[4]  
Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192
[5]   OPPORTUNITIES AND RESPONSIBILITIES IN PHARMACEUTICAL CARE [J].
HEPLER, CD ;
STRAND, LM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (03) :533-543
[6]   DRUG-RELATED MORBIDITY AND MORTALITY - A COST-OF-ILLNESS MODEL [J].
JOHNSON, JA ;
BOOTMAN, JL .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) :1949-1956
[7]   The Role of Pharmacy Through Collaborative Practice in an Ambulatory Care Clinic [J].
Jun, Jeany Kim .
AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2019, 13 (03) :275-281
[8]  
Manley HJ, 2020, AM J KIDNEY DIS, V76, P13, DOI 10.1053/j.ajkd.2019.12.002
[9]   Medication-related problems in ambulatory hemodialysis patients: A pooled analysis [J].
Manley, HJ ;
Cannella, CA ;
Bailie, GR ;
St Peter, WL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) :669-680
[10]   Reduced Drug Use and Hospitalization Rates in Patients Undergoing Hemodialysis Who Received Pharmaceutical Care: A 2-Year, Randomized, Controlled Study [J].
Pai, Amy Barton ;
Boyd, Alex ;
Depczynski, Joseph ;
Chavez, Isela Martinez ;
Khan, Nasreen ;
Manley, Harold .
PHARMACOTHERAPY, 2009, 29 (12) :1433-1440